Matt Abernethy, Chief Financial Officer

Professional Overview

Matt Abernethy is an accomplished financial executive with extensive experience in the life sciences and healthcare industries. As the Chief Financial Officer of Neurocrine Biosciences, he is responsible for overseeing the company's financial strategy, operations, and reporting, contributing to its growth and success.

Experience Summary

Current Role

Matt Abernethy has served as the Chief Financial Officer of Neurocrine Biosciences since November 2017. In this role, he is responsible for managing the company's financial affairs, including financial planning, budgeting, and reporting. He also plays a key role in strategic decision-making, supporting Neurocrine's expansion and the development of its innovative therapeutic solutions.

Career Progression

Prior to joining Neurocrine Biosciences, Matt held various finance leadership positions at Zimmer Biomet, a global medical device company. From 2017 to 2017, he served as the Vice President of Investor Relations and Treasurer, where he was instrumental in strengthening the company's financial communication with investors. Before that, he served as the Vice President of Finance at Zimmer Biomet from 2015 to 2017.

Earlier in his career, Matt held several finance roles at Biomet, a leading orthopedic device manufacturer, from 2009 to 2015, including Vice President of Finance. He also gained valuable experience as the Vice President of Finance at True Homes, a real estate development company, and as a Senior Associate at KPMG US, a prominent accounting and consulting firm.

Academic Background

Matt Abernethy holds a Bachelor's degree in Accounting from the University of Notre Dame, where he graduated with distinction.

Areas of Expertise

Matt Abernethy's areas of expertise include financial planning and analysis, treasury management, investor relations, and strategic financial decision-making. He has a deep understanding of the life sciences and healthcare industries, having worked with leading companies in these sectors throughout his career.

Professional Impact

Throughout his career, Matt has played a pivotal role in driving financial performance, improving operational efficiency, and supporting the strategic objectives of the organizations he has served. At Neurocrine Biosciences, he is leveraging his extensive finance and industry expertise to contribute to the company's continued growth and success.

Conclusion

With his proven track record of financial leadership, industry knowledge, and strategic acumen, Matt Abernethy is well-positioned to drive Neurocrine Biosciences' financial and operational success as its Chief Financial Officer. His commitment to excellence and collaborative approach make him a valuable asset to the organization.